Funded Startups in Durham
Durham-linked funding in this snapshot spans from 2024-03-15 (Verinetics, $150K) to 2026-06-30 (Higharc, $95M), and the disclosed amounts show a wide spread.
Durham-linked funding in this snapshot spans from 2024-03-15 (Verinetics, $150K) to 2026-06-30 (Higharc, $95M), and the disclosed amounts show a wide spread. The only disclosed round above $50M is Higharc’s $95M on 2026-06-30, which dwarfs the next-largest disclosed amounts of $431M (Vulcan Elements, 2026-04-02) and $150M (Atsena Therapeutics, 2025-04-02; Neurophos, 2026-01-22). At the low end, the smallest disclosed amount is The ReCollective’s $10K on 2025-05-01, while multiple entries remain amount-undisclosed (5 “undisclosed” amounts: Ten63 Therapeutics 2026-02-19, Kramden Institute 2025-06-25, Regrow Ag 2025-03-26, Bionic Health 2024-10-01, Carpe 2024-08-20; plus one blank “Series” field for InnovationForce and Verinetics). Most entries cluster by geography around “Durham, North Carolina” (with additional rows in Durham, New Hampshire; Durham, United Kingdom; Durham, Connecticut), and by timing: several large rounds land in 2025 Q4 (e.g., Looma $10M on 2025-12-16; Sennos $20M on 2026-04-08 sits outside that window). Sector and stage labeling are also skewed, with “Artificial Intelligence (AI)” appearing in multiple entries (Keebler Health 2026-04-15; Ramona 2026-03-11; Neurophos 2026-01-22; Restor3d 2025-08-22; plus others) and “Series Unknown” showing up frequently (10 rows) alongside a mix of Seed, Pre-Seed, and Series rounds.
Most recent rounds
50 shownRelated listings
Frequently asked
Which recent disclosed round is the size outlier in the Durham listings, and what’s the closest competing disclosed number?
Higharc reported $95M on 2026-06-30, but the larger disclosed outlier in this set is Vulcan Elements’ $431M on 2026-04-02; the next-largest disclosed amounts sit far below those levels, including $150M for both Atsena Therapeutics (2025-04-02) and Neurophos (2026-01-22).
How tight is the timing window for the most recent entries compared with the oldest disclosed rounds?
The listing’s latest round date is 2026-06-30 (Higharc, $95M), while the oldest dated row shown is 2024-03-15 (Verinetics, $150K). Several entries cluster in 2026 (e.g., multiple June 2026 rounds: Protect3d on 2026-06-04 at $850K and Arpio on 2026-06-03 at $15M), indicating a heavy skew toward the last few quarters of the date range.
Are any cities under “Durham” over-represented, or is the list spread across multiple Durhams?
The majority of rows are explicitly “Durham, North Carolina” (e.g., Higharc 2026-06-30 $95M; Arpio 2026-06-03 $15M; Neurophos 2026-01-22 $110M). Other Durhams appear but less frequently, including Durham, New Hampshire (Coastal Measures, 2026-04-06, $1M) and Durham, Connecticut (Trosa 2024-11-22 $1M; Energea 2024-08-28 $670K), plus Durham, United Kingdom (Feasibly, 2025-12-03, $270K).
What stage and label mix dominates these rounds, especially around “Series Unknown” and undisclosed amounts?
“Series Unknown” appears often: Galaxy Diagnostics (2026-06-03, $3M), Sennos (2026-04-08, $20M), Vulcan Elements (2026-04-02, $431M), and multiple others, totaling 10 “Series Unknown” rows in the 50 shown. Separately, 5 entries list amounts as “undisclosed” (e.g., Ten63 Therapeutics on 2026-02-19; Bionic Health on 2024-10-01; Carpe on 2024-08-20), with two additional rows missing a “Series” label (InnovationForce 2024-03-26; Verinetics 2024-03-15).
Which sectors show a repeated presence, and which sector entries include some of the largest disclosed rounds?
Artificial Intelligence (AI) recurs across multiple entries (Keebler Health, 2026-04-15, $16M; Ramona, 2026-03-11, $26M; Neurophos, 2026-01-22, $110M; Restor3d, 2025-08-22, $104M; and others). Large disclosed rounds also appear outside AI, including Vulcan Elements in Manufacturing at $431M (2026-04-02) and Leyline Renewable Capital in Energy at $140M (2024-12-10).
Are there other extreme low-end disclosed amounts worth flagging for deal-sizing conversations?
At the low end, The ReCollective’s $10K round on 2025-05-01 stands out as the smallest disclosed amount in the rows shown. Several other small datapoints sit well under the mid-range, including EydisBio at $500K (2024-10-23) and aXenic at $670K (2025-10-07), which can be useful for benchmarking when most late rounds are tens of millions (e.g., Higharc $95M on 2026-06-30).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.